The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Swine Vaccines Market Research Report 2024
Synopsis
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The global Swine Vaccines market was valued at US$ 1379.2 million in 2023 and is anticipated to reach US$ 1820.9 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
Report Scope
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The global Swine Vaccines market was valued at US$ 1379.2 million in 2023 and is anticipated to reach US$ 1820.9 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
Report Scope
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Swine Vaccines Market Overview
1.1 Product Overview and Scope of Swine Vaccines
1.2 Swine Vaccines Segment by Type
1.2.1 Global Swine Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines Segment by Application
1.3.1 Global Swine Vaccines Market Value by Application: (2024-2030)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Vaccines Revenue 2019-2030
1.4.2 Global Swine Vaccines Sales 2019-2030
1.4.3 Global Swine Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Swine Vaccines Market Competition by Manufacturers
2.1 Global Swine Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Swine Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Swine Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Swine Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Vaccines, Product Type & Application
2.7 Swine Vaccines Market Competitive Situation and Trends
2.7.1 Swine Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Vaccines Players Market Share by Revenue
2.7.3 Global Swine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Vaccines Retrospective Market Scenario by Region
3.1 Global Swine Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Swine Vaccines Global Swine Vaccines Sales by Region: 2019-2030
3.2.1 Global Swine Vaccines Sales by Region: 2019-2024
3.2.2 Global Swine Vaccines Sales by Region: 2025-2030
3.3 Global Swine Vaccines Global Swine Vaccines Revenue by Region: 2019-2030
3.3.1 Global Swine Vaccines Revenue by Region: 2019-2024
3.3.2 Global Swine Vaccines Revenue by Region: 2025-2030
3.4 North America Swine Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Swine Vaccines Sales by Country (2019-2030)
3.4.3 North America Swine Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Swine Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Swine Vaccines Sales by Country (2019-2030)
3.5.3 Europe Swine Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Swine Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Swine Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Swine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Swine Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Swine Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Swine Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Swine Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Swine Vaccines Sales by Type (2019-2030)
4.1.1 Global Swine Vaccines Sales by Type (2019-2024)
4.1.2 Global Swine Vaccines Sales by Type (2025-2030)
4.1.3 Global Swine Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Swine Vaccines Revenue by Type (2019-2030)
4.2.1 Global Swine Vaccines Revenue by Type (2019-2024)
4.2.2 Global Swine Vaccines Revenue by Type (2025-2030)
4.2.3 Global Swine Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Swine Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Swine Vaccines Sales by Application (2019-2030)
5.1.1 Global Swine Vaccines Sales by Application (2019-2024)
5.1.2 Global Swine Vaccines Sales by Application (2025-2030)
5.1.3 Global Swine Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Swine Vaccines Revenue by Application (2019-2030)
5.2.1 Global Swine Vaccines Revenue by Application (2019-2024)
5.2.2 Global Swine Vaccines Revenue by Application (2025-2030)
5.2.3 Global Swine Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Swine Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Corporation Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Corporation Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Corporation Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Corporation Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Corporation Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Corporation Information
6.11.2 Hipra Swine Vaccines Description and Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Swine Vaccines Description and Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Corporation Information
6.13.2 ChengDu Tecbond Swine Vaccines Description and Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments/Updates
6.14 DHN
6.14.1 DHN Corporation Information
6.14.2 DHN Swine Vaccines Description and Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Corporation Information
6.15.2 CAVAC Swine Vaccines Description and Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Corporation Information
6.16.2 Virbac Swine Vaccines Description and Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 HVRI
6.17.1 HVRI Corporation Information
6.17.2 HVRI Swine Vaccines Description and Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments/Updates
6.18 Bioveta
6.18.1 Bioveta Corporation Information
6.18.2 Bioveta Swine Vaccines Description and Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Vaccines Industry Chain Analysis
7.2 Swine Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Vaccines Production Mode & Process
7.4 Swine Vaccines Sales and Marketing
7.4.1 Swine Vaccines Sales Channels
7.4.2 Swine Vaccines Distributors
7.5 Swine Vaccines Customers
8 Swine Vaccines Market Dynamics
8.1 Swine Vaccines Industry Trends
8.2 Swine Vaccines Market Drivers
8.3 Swine Vaccines Market Challenges
8.4 Swine Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
